4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-23-002144
Options or other derivatives
- Chief Executive Officer acquired 177,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brady Stephen R Chief Executive Officer | 2023-01-03 | Grant or award · Employee Stock Option (right to buy) | +177,300 | 177,300 | D | ||
Loading xslF345X03/doc4.xml…